EUVIMEDEUVIMED entdecken
Open Access

Anabolic Androgenic Steroids: Emerging Use Disorder, Mechanisms of Action, and Clinical Considerations for Pharmacotherapy

Eric Kutscher iD, Elena Silverman iD, Keren Bachi iD

Focus · 2026-04 · 24 (2) · 168-178

DOI: 10.1176/appi.focus.20250045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Focus, 2026-04. Verfasst von Eric Kutscher und 2 weiteren Autor:innen. Beteiligte Einrichtung: Divison of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Divison of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York.
  • Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York.
  • Department of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York.

ORCID-Profile: Eric Kutscher, Elena Silverman, Keren Bachi

Förderung

  • NIMH NIH HHS

Zitieren

APA

Kutscher, E., Silverman, E., & Bachi, K. (2026). Anabolic Androgenic Steroids: Emerging Use Disorder, Mechanisms of Action, and Clinical Considerations for Pharmacotherapy. Focus, 24(2), 168-178. https://doi.org/10.1176/appi.focus.20250045

Vancouver

Kutscher E, Silverman E, Bachi K. Anabolic Androgenic Steroids: Emerging Use Disorder, Mechanisms of Action, and Clinical Considerations for Pharmacotherapy. Focus. 2026;24(2):168-178. doi:10.1176/appi.focus.20250045

BibTeX
@article{Kutscher2026,
  author = {Kutscher, Eric and Silverman, Elena and Bachi, Keren},
  title = {Anabolic Androgenic Steroids: Emerging Use Disorder, Mechanisms of Action, and Clinical Considerations for Pharmacotherapy},
  journal = {Focus},
  year = {2026},
  volume = {24},
  number = {2},
  pages = {168--178},
  doi = {10.1176/appi.focus.20250045}
}
Kostenlos starten →